Notice of Annual General Meeting
Oslo, Norway, 16 April 2007
Please find enclosed an invitation to the annual general meeting at Photocure ASA on 25 April 2007, attendance slip and annual report 2006 in English.
Please find enclosed an invitation to the annual general meeting at Photocure ASA on 25 April 2007, attendance slip and annual report 2006 in English.
For further information, please contact:
President and CEO Kjetil Hestdal
E-mail: kh@photocure.no
Mobile: +47 913 19 535
CFO Christian Fekete
E-mail: cf@photocure.no
Mobile: +47 916 42 938
www.photocure.com
Photocure ASA is a Norwegian pharmaceutical company listed on the Oslo Stock Exchange. The company develops and sells pharmaceuticals and medical devices for the photodynamic treatment and diagnosis of different types of cancer.
Photocure has three products on the market: Metvix® cream and the light source Aktilite® for the treatment of sun-damaged skin and certain types of skin cancer, and Hexvix® for the diagnosis of bladder cancer. In addition, the company has several follow-on products and technologies in the pipeline.